Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Intravenous Equipment Market, by Product Type
1.4.2 North America Intravenous Equipment Market, by End User
1.4.3 North America Intravenous Equipment Market, by Country
1.5 Methodology for the research
Chapter 2. Market at a Glance
2.1 Key Highlights
Chapter 3. Market Overview
3.1 Introduction
3.1.1 Overview
3.1.1.1 Market Composition and Scenario
3.2 Key Factors Impacting the Market
3.2.1 Market Drivers
3.2.2 Market Restraints
3.3 Porter Five Forces Analysis
Chapter 4. Strategies Deployed in Intravenous Equipment Market
Chapter 5. North America Intravenous Equipment Market by Product Type
5.1 North America IV catheters Market by Country
5.2 North America Infusion Pumps Market by Country
5.3 North America Administration Sets Market by Country
5.4 North America Needleless Connectors Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Intravenous Equipment Market by End User
6.1 North America Hospitals & Clinics Market by Country
6.2 North America Homecare Settings Market by Country
6.3 North America Others Market by Country
Chapter 7. North America Intravenous Equipment Market by Country
7.1 US Intravenous Equipment Market
7.1.1 US Intravenous Equipment Market by Product Type
7.1.2 US Intravenous Equipment Market by End User
7.2 Canada Intravenous Equipment Market
7.2.1 Canada Intravenous Equipment Market by Product Type
7.2.2 Canada Intravenous Equipment Market by End User
7.3 Mexico Intravenous Equipment Market
7.3.1 Mexico Intravenous Equipment Market by Product Type
7.3.2 Mexico Intravenous Equipment Market by End User
7.4 Rest of North America Intravenous Equipment Market
7.4.1 Rest of North America Intravenous Equipment Market by Product Type
7.4.2 Rest of North America Intravenous Equipment Market by End User
Chapter 8. Company Profiles
8.1 AngioDynamics, Inc.
8.1.1 Company Overview
8.1.2 Financial Analysis
8.1.3 Segmental and Regional Analysis
8.1.4 Research & Development Expenses
8.1.5 SWOT Analysis
8.2 B. Braun Melsungen AG
8.2.1 Company Overview
8.2.2 Financial Analysis
8.2.3 Segmental and Regional Analysis
8.2.4 Research & Development Expenses
8.2.5 Recent strategies and developments:
8.2.5.1 Acquisition and Mergers:
8.2.6 SWOT Analysis
8.3 ICU Medical, Inc.
8.3.1 Company Overview
8.3.2 Financial Analysis
8.3.3 Regional Analysis
8.3.4 Research & Development Expenses
8.3.5 Recent strategies and developments:
8.3.5.1 Acquisition and Mergers:
8.3.6 SWOT Analysis
8.4 3M Company
8.4.1 Company Overview
8.4.2 Financial Analysis
8.4.3 Segmental and Regional Analysis
8.4.4 Research & Development Expense
8.4.5 SWOT Analysis
8.5 Teleflex, Inc.
8.5.1 Company Overview
8.5.2 Financial Analysis
8.5.3 Segmental Analysis
8.5.4 Research & Development Expense
8.5.5 Recent strategies and developments:
8.5.5.1 Acquisition and Mergers:
8.5.6 SWOT Analysis
8.6 Terumo Corporation
8.6.1 Company Overview
8.6.2 Financial Analysis
8.6.3 Segmental and Regional Analysis
8.6.4 Research & Development Expenses
8.6.5 Recent strategies and developments:
8.6.5.1 Acquisition and Mergers:
8.6.6 SWOT Analysis
8.7 Baxter International, Inc.
8.7.1 Company Overview
8.7.2 Financial Analysis
8.7.3 Segmental Analysis
8.7.4 Research & Development Expense
8.7.5 Recent strategies and developments:
8.7.5.1 Acquisition and Mergers:
8.7.6 SWOT Analysis
8.8 Becton, Dickinson, and Company
8.8.1 Company Overview
8.8.2 Financial Analysis
8.8.3 Segmental and Regional Analysis
8.8.4 Research & Development Expense
8.8.5 Recent strategies and developments:
8.8.5.1 Acquisition and Mergers:
8.8.6 SWOT Analysis
8.9 VYGON
8.9.1 Company Overview
8.9.2 SWOT Analysis
8.10. Poly Medicure Ltd.
8.10.1 Company Overview
8.10.2 Financial Analysis
8.10.3 Regional Analysis
8.10.4 Research & Development Expenses
8.10.5 SWOT Analysis
Unique Offerings 